Stock Market

What’s occurring with overseas college students in Canada? | Canada visa | Canada college students

4Dec

By Business Standard41 Comments

News & Events

What’s occurring with overseas college students in Canada? | Canada visa | Canada college students

Over 70,000 worldwide scholar graduates throughout Canada are going through the specter of deportation. Affected college students, many from India, have rallied in cities corresponding to Ontario, Manitoba, Prince Edward Island, and British Columbia to guard their proper to stay in Canada. Watch the video to seek out out why. #canada #visa #canadastudyvisa Hi there viewers! Guess what? We're now on WhatsApp Channels! Dive into real-time information updates, insights, and rather more. Observe us: https://whatsapp.com/channel/0029Va6cbsSDuMRmPCIgXS2t Subscribe to BS Hindi YouTube Channel: https://www.youtube.com/@bshindinews Obtain the all-new Enterprise Commonplace app: https://bit.ly/App-BS Be part of us: http://www.fb.com/bsindia http://twitter.com/bsindia https://www.instagram.com...

11Nov

By Dividend Data37 Comments

News & Events

Visa Stock Falls After DOJ Lawsuit, Nancy Pelosi Sold Again

✍️ My Free Publication: https://dividenddata.beehiiv.com/subscribe?utm_source=youtube 💻 The Greatest Stock Analysis Instrument: https://www.dividenddata.com/ At the moment, the US Division of Justice introduced a lawsuit alleging that Visa is a monopolist. They declare that the corporate has been concerned in anti-competitive techniques to regulate the debit transactions market. Following the information, Visa inventory fell 5.49%. This lawsuit comes after Nancy Pelosi bought $1 million of Visa inventory only a few months in the past. Humorous how that continues to occur. My Hyperlinks: Merch Retailer: https://store.dividenddata.com/ Comply with on X: https://x.com/dividend_data Pay attention on Spotify: https://open.spotify.com/present/4dBCd8IWgBYJgrbI2zROPR?si=084da0648e694103 Help on...

1Nov

By Dividendology50 Comments

News & Events

VISA Stock is Cheaper Than it Was 5 Years Ago! | Visa (V) Stock Analysis! |

🚀 Entry Tickerdata and my Spreadsheets: https://tickerdata.com/ 💰Get $25 off and a 7 day free trial to Searching for Alpha: https://www.seekingalpha.hyperlink/9D5QH2/2QZRGT/ 🔥Be part of my free publication! https://dividendology.substack.com/ On this video, I clarify why Visa inventory is cheaper than it was 5 years in the past. Let me know your ideas within the feedback beloW Most well-liked Dealer (Interactive Brokers): https://www.interactivebrokers.com/mkt/?src=dividendologyPY1&url=%2Fenpercent2Fwhyibpercent2Foverview.php Subscribe to my second channel: https://www.youtube.com/@tickerdata/movies Social Media (and different enjoyable stuff): https://linktr.ee/dividendology I'm not a Monetary advisor or licensed skilled. Nothing I say or produce on YouTube, or wherever else, oug...

2Feb

By UNN News DeskNo Comments

News & Events, Business

Why Gilead Sciences Stock Nosedived on Monday

NASDAQ: Gilead Sciences (GILD), a sturdy in the drug area, encountered a difficult day in the stock trade this Monday. Financial backers answered disheartening clinical preliminary outcomes for one of its investigational drugs by driving the organization's portion cost somewhere around more than 10%, even as the more extensive S&P 500 list shut emphatically, acquiring almost 0.3%. Gilead Sciences Stock down on Monday Image credits: https://www.tradingview.com/ The difficulty happened in a late-stage preliminary for Trodelvy, a supported malignant growth drug. Gilead wanted to include patients with advanced or metastatic non-small cell lung cancer (NSCLC) who had progressed after platinum-based chemotherapy and checkpoint inhibitor therapy in the scope of its FDA approval. Sad...

2Feb

By Richard TurnerNo Comments

News & Events, Technology and Ai

FDA approves Vertex/CRISPR Gene Therapy for Inherited Blood Disorders

FDA approves Vertex/CRISPR Gene Therapy for Inherited Blood Disorders In a monumental leap for gene therapy and a beacon of hope for millions suffering from life-threatening blood disorders, the US Food and Drug Administration (FDA) has granted approval to Vertex Pharmaceuticals and CRISPR Therapeutics' revolutionary treatment - Exa-cel (casgenevo). This breakthrough represents a new era in treating genetic diseases, paving the way for personalized, curative therapies once relegated to the realm of science fiction. Understanding the Blood Disorder Battleground: Inherited blood disorders, such as transfusion-dependent beta-thalassemia and sickle cell disease, affect millions worldwide. These debilitating conditions are caused by genetic mutations that impair the production or function ...